Home » Clinical Trials » Atrial Flutter
Clinical Trial Details
Research Study Summary
A clinical trial to evaluate treatments using tricuspid isthmus imaging with Cartosound for patients with Atrial Flutter
Research Study Title
Tricuspid Isthmus Architecture as Imaged by CARTOsound, Determines Ablation Times in Patients With Typical Atrial Flutter
The investigators propose a third hypothesis based on the anatomic observations made in
pathological studies. The investigators hypothesize that the anatomic architecture
determines the functional properties of the TV-IVC isthmus. As a result,
• Muscular bundles are preferential routes of conduction through the TV-IVC isthmus. The
isthmus acts like a series of discreet conduction routes rather than as a sheet of tissue.
The muscular bundles form selective targets for ablation and therefore the entire anatomic
line need not be ablated. This has direct implications for ablation of the isthmus.
To Learn more
Both Male and Female
Both Male and Female ages 18 Years and up
- Patients must be over 18 years of age provided written informed consent documented
atrial flutter by ECG , holter monitor or TTM
- previous atrial flutter ablation non isthmus dependent atrial flutter prior right
Site Locations (1)
||London Health Sciences Center
NCT ID: NCT01113788
Date Last Changed: April 29, 2010
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.